神经肌肉阻滞剂对中重度急性呼吸窘迫综合征跨肺压的影响
该前瞻性随机对照研究纳入30例中重度ARDS患者(中度24例,重度6例),所有患者经食管导管监测48小时。中度ARDS患者随机分为接受苯磺顺阿曲库铵48小时持续输注组与对照组,重度ARDS患者不予随机化且全部按方案接受苯磺顺阿曲库铵。结果显示,神经肌肉阻滞剂输注在中度和重度ARDS中均与氧合改善相关,同时伴随平台压和总呼气末正压下降。接受神经肌肉阻滞剂的中度ARDS组平均吸气和呼气跨肺压高于对照组,但驱动压和ΔP L与神经肌肉阻滞剂给药无关,无变化。作者结论认为,神经肌肉阻滞剂可能通过限制呼气努力对中度ARDS患者产生有益效应。
要点
- 中重度ARDS患者使用苯磺顺阿曲库铵48小时持续输注,中度和重度ARDS均观察到氧合改善,伴平台压和总呼气末正压下降。
- 接受神经肌肉阻滞剂的中度ARDS组平均吸气和呼气跨肺压高于对照组,但驱动压和ΔP L与给药无关、无变化。
- 研究纳入30例患者(中度ARDS 24例,重度ARDS 6例),全部经食管导管监测并随访48小时,重度ARDS患者未随机化、全部按方案接受苯磺顺阿曲库铵。
- 作者结论认为,神经肌肉阻滞剂可能通过限制呼气努力对中度ARDS患者产生有益效应。
适用人群与场景
- 中重度ARDS且处于ARDS发病48小时内的患者。
- 中度ARDS患者随机分为接受或不接受苯磺顺阿曲库铵48小时持续输注两组。
- 重度ARDS患者不进行随机化,全部按方案接受苯磺顺阿曲库铵。
处置流程与药物剂量
- 中度ARDS组随机接受苯磺顺阿曲库铵48小时持续输注或不接受(对照组)。
- 重度ARDS患者全部按方案接受苯磺顺阿曲库铵。
- 所有患者经食管导管监测,随访48小时,评估氧合和呼吸力学(包括吸气和呼气跨肺压及驱动压)的变化。
研究设计与关键结果
- 前瞻性随机对照研究,纳入30例中重度ARDS患者(中度ARDS 24例,重度ARDS 6例),全部经食管导管监测并随访48小时。
- 神经肌肉阻滞剂输注在中度和重度ARDS中均与氧合改善相关,同时伴随平台压和总呼气末正压下降。
- 接受神经肌肉阻滞剂的中度ARDS组平均吸气和呼气跨肺压高于对照组。
- 驱动压和ΔP L与神经肌肉阻滞剂给药无关,无变化。
证据类型、等级与局限
- 证据类型:前瞻性随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,神经肌肉阻滞剂可能通过限制呼气努力对中度ARDS患者产生有益效应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To investigate whether neuromuscular blocking agents (NMBA) exert beneficial effects in acute respiratory distress syndrome (ARDS) by reason of their action on respiratory mechanics, particularly transpulmonary pressures (P L).
METHODS: A prospective randomised controlled study in patients with moderate to severe ARDS within 48 h of the onset of ARDS. All patients were monitored by means of an oesophageal catheter and followed up for 48 h. Moderate ARDS patients were randomised into two groups according to whether they were given a 48-h continuous infusion of cisatracurium besylate or not (control group). Severe ARDS patients did not undergo randomisation and all received cisatracurium besylate per protocol. The changes during the 48-h study period in oxygenation and in respiratory mechanics, including inspiratory and expiratory P L and driving pressure, were assessed and compared. Delta P L (∆P L) was defined as inspiratory P L minus expiratory P L.
RESULTS: Thirty patients were included, 24 with moderate ARDS and 6 with severe ARDS. NMBA infusion was associated with an improvement in oxygenation in both moderate and severe ARDS, accompanied by a decrease in both plateau pressure and total positive end-expiratory pressure. The mean inspiratory and expiratory P L were higher in the moderate ARDS group receiving NMBA than in the control group. In contrast, there was no change in either driving pressure or ∆P L related to NMBA administration.
CONCLUSIONS: NMBA could exert beneficial effects in patients with moderate ARDS, at least in part, by limiting expiratory efforts.
参考来源
- Guervilly C, Bisbal M, Forel JM, et al. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Intensive Care Med. 2016. PMID: 28013329. doi:10.1007/s00134-016-4653-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。